| P50 | author | Margherita Macera | Q92193504 |
| | Evangelista Sagnelli | Q41549310 |
| | Caterina Sagnelli | Q42257713 |
| | Lorenzo Onorato | Q55446178 |
| | Mariantonietta Pisaturo | Q56855268 |
| | Salvatore Martini | Q123357978 |
| P2093 | author name string | Nicola Coppola | |
| P2860 | cites work | Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study | Q80242524 |
| | Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection | Q81066450 |
| | Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors | Q84146519 |
| | Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients | Q27477975 |
| | HCV genotype 2 as a risk factor for reactivation of chronic HCV infection | Q27477985 |
| | Global epidemiology of hepatitis C virus infection | Q27860799 |
| | Replication of hepatitis C virus | Q27860957 |
| | Hepatitis C virus infection | Q27861002 |
| | Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C | Q28539814 |
| | Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 |
| | Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 |
| | Natural history of chronic hepatitis C | Q29620673 |
| | Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection | Q33735206 |
| | Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection | Q33867583 |
| | Noncytolytic control of viral infections by the innate and adaptive immune response | Q34178107 |
| | Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? | Q34296276 |
| | Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy | Q34387913 |
| | Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals | Q34540287 |
| | Occult hepatitis B. | Q34768651 |
| | Surveillance for acute viral hepatitis - United States, 2007. | Q34983660 |
| | Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. | Q35100009 |
| | High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan | Q35356183 |
| | Global burden of disease (GBD) for hepatitis C. | Q35610002 |
| | Chronic hepatitis C: an age wave of disease burden. | Q36289402 |
| | Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Q36346436 |
| | Occult HBV infection | Q36518847 |
| | Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study. | Q37009627 |
| | Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C. | Q37439935 |
| | Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009. | Q38916127 |
| | Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients | Q38989985 |
| | Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours | Q39795088 |
| | Mutations of the X region of hepatitis B virus and their clinical implications | Q41431445 |
| | TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism | Q41549262 |
| | Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. | Q42234731 |
| | Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection | Q42245958 |
| | Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C. | Q42266477 |
| | Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. | Q42287432 |
| | Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection | Q42918481 |
| | Influence of chronic coinfection with hepatitis B and C virus on liver histology. | Q42985571 |
| | Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence | Q42986748 |
| | Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients | Q42987544 |
| | Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up | Q42989472 |
| | A cluster of acute hepatitis C virus infection among men who have sex with men--results from contact tracing and public health implications | Q42992526 |
| | Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease | Q42994045 |
| | Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance | Q42994702 |
| | Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients | Q42998045 |
| | Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study | Q42999098 |
| | Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. | Q42999305 |
| | Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis | Q43000718 |
| | Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation | Q43001140 |
| | The impact of previous HBV infection on the course of chronic hepatitis C. | Q43001703 |
| | Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. | Q43032166 |
| | Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission | Q43038483 |
| | Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil | Q43039391 |
| | Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study | Q43039760 |
| | Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients | Q43040870 |
| | Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. | Q43047549 |
| | Lack of epidemiological evidence for a role of resolved hepatitis B virus infection in hepatocarcinogenesis in patients infected with hepatitis C virus in Japan | Q43047645 |
| | Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. | Q43048053 |
| | Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients | Q43049239 |
| | Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients | Q43408598 |
| | Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C. | Q44156126 |
| | Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. | Q44264639 |
| | Factors associated with the development of cirrhosis in patients with HCV chronic infection. | Q44384828 |
| | High prevalence of occult hepatitis B in Baltimore injection drug users | Q44616955 |
| | Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C | Q44618806 |
| | Occult hepatitis B virus in liver tissue of individuals without hepatic disease | Q44790133 |
| | Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease | Q44821221 |
| | Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. | Q45350818 |
| | Statements from the Taormina expert meeting on occult hepatitis B virus infection | Q45391959 |
| | Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus | Q45394122 |
| | Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study | Q45396416 |
| | Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails | Q45397975 |
| | Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease | Q45398752 |
| | The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients | Q45468877 |
| | Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres | Q45483149 |
| | Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C. | Q45494455 |
| | Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. | Q45701679 |
| | Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation | Q45739211 |
| | Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen | Q45755642 |
| | Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis | Q45767597 |
| | The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. | Q45770371 |
| | HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. | Q46099371 |
| | Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis | Q46476300 |
| | Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. | Q50560155 |
| | Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. | Q50571483 |
| | Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study. | Q50615376 |
| | Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C. | Q50707984 |
| | Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. | Q54523160 |
| | Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. | Q54543274 |
| | Long-term histologic and virologic outcomes of acute self-limited hepatitis B. | Q54776085 |
| | Acute hepatitis C | Q73427444 |
| | Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? | Q73928764 |
| | Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group | Q77747375 |
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| | Hepatitis B virus | Q6844 |
| | hepatitis B | Q6853 |
| | virology | Q7215 |
| | chronic hepatitis C | Q55779873 |
| | chronic hepatitis | Q62019625 |
| P304 | page(s) | 11931-11940 | |
| P577 | publication date | 2015-11-14 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Role of occult hepatitis B virus infection in chronic hepatitis C | |
| P478 | volume | 21 | |